ArticleRheumatology advances in practice2023

Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials.

Philip G Conaghan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.